Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00
Provider: ValuEngine, Inc.
$25.00
Provider: S&P Capital IQ Quantitative Report
$127.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Streamline Health Solutions gives FY 2014 guidance - Conference Call


Monday, 16 Jun 2014 12:30pm EDT 

Streamline Health Solutions Inc:Expects FY 2014 top-line revenue to grow to $35 to $37 mln including the assets acquired in the Unibased acquisition.Expects FY 2014 adjusted EBITDA to expand to $6 to $7 mln.FY 2014 revenue of $36 mln and EBITDA of $7 mln - Thomson Reuters I/B/E/S. 

Company Quote

4.24
0.19 +4.69%
19 Dec 2014